XOMA-Logo-Final.png
XOMA Appoints W. Denman Van Ness as Lead Independent Director
January 18, 2008 08:05 ET | XOMA Corporation
BERKELEY, Calif., Jan. 18, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that its Board of Directors has...
XOMA-Logo-Final.png
XOMA Speaks On Diabetes and Obesity Panel At RBC Capital Markets Healthcare Conference
December 06, 2007 16:35 ET | XOMA Corporation
BERKELEY, Calif., Dec. 6, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
XOMA-Logo-Final.png
XOMA Announces Conference Call to Provide Overview of Business Strategy
November 26, 2007 16:01 ET | XOMA Corporation
BERKELEY, Calif., Nov. 26, 2007 (PRIME NEWSWIRE) -- XOMA, Ltd., (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today will host a conference call and live webcast to...
XOMA-Logo-Final.png
XOMA to Present At Lazard Capital Markets Healthcare Conference On November 27
November 15, 2007 08:05 ET | XOMA Corporation
BERKELEY, Calif., Nov. 15, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
XOMA-Logo-Final.png
XOMA Reports Third Quarter 2007 Financial Results
November 08, 2007 04:00 ET | XOMA Corporation
BERKELEY, Calif., Nov. 8, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced its results for the quarter ended...
XOMA-Logo-Final.png
XOMA to Announce Third Quarter 2007 Financial Results and Host Conference Call On Thursday, November 8
November 01, 2007 16:35 ET | XOMA Corporation
BERKELEY, Calif., Nov. 1, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that the Company will host a conference call...
XOMA-Logo-Final.png
XOMA to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference
October 30, 2007 16:40 ET | XOMA Corporation
BERKELEY, Calif., Oct. 30, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
XOMA-Logo-Final.png
Steven Engle Appointed Chairman of XOMA
October 08, 2007 08:05 ET | XOMA Corporation
BERKELEY, Calif., Oct. 8, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today announced the appointment of its Chief Executive...
XOMA-Logo-Final.png
XOMA to Present At 2007 BIO Investor Forum
October 03, 2007 16:05 ET | XOMA Corporation
BERKELEY, Calif., Oct. 3, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, XOMA's Chief...
XOMA-Logo-Final.png
XOMA Initiates Phase 1 European Trial in Diabetes for XOMA 052, a Novel Anti-IL-1 Antibody Designed to Target Diabetes, Rheumatoid Arthritis and Other Inflammatory Diseases
September 12, 2007 08:05 ET | XOMA Corporation
BERKELEY, Calif., Sept. 12, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) today announced the start of a second Phase 1 clinical study of XOMA 052, a potent monoclonal antibody targeting...